跳转至内容
Merck
  • Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.

Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England) (2014-05-21)
Michael P Pender, Peter A Csurhes, Casey Mm Pfluger, Scott R Burrows
摘要

Patients with multiple sclerosis (MS) have a deficiency of circulating CD8+ T cells, which might impair control of Epstein-Barr virus (EBV) and predispose to MS by allowing EBV-infected autoreactive B cells to accumulate in the central nervous system. Based on the expression of CD45RA and CD62L, CD4+ T cells and CD8+ T cells can be subdivided into four subsets with distinct homing and functional properties, namely: naïve, central memory, effector memory (EM) and effector memory re-expressing CD45RA (EMRA) cells. Our aim was to determine which memory subsets are involved in the CD8+ T cell deficiency and how these relate to clinical course. We used flow cytometry to analyze the memory phenotypes of T cells in the blood of 118 MS patients and 112 healthy subjects. MS patients had a decreased frequency of EM (CD45RA(-)CD62L(-)) and EMRA (CD45RA(+)CD62L(-)) CD8+ T cells, which was present at the onset of disease and persisted throughout the clinical course. The frequencies of CD4+ EM and EMRA T cells were normal. Deficiency of effector memory CD8+ T cells is an early and persistent feature of MS and might underlie the impaired CD8+ T cell control of EBV.

材料
货号
品牌
产品描述

Sigma-Aldrich
Aphidicolin from Nigrospora sphaerica, ≥98% (HPLC), powder
Supelco
Aphidicolin, analytical standard